EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $2.1B
- YoY, 2025
- +16.5%
- 5-year CAGR
- +11.2%
- 10-year CAGR
- +9.4%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $2.1B | +16.5% |
| 2024 | $1.8B | +13.1% |
| 2023 | $1.6B | +16.6% |
| 2022 | $1.4B | −9.1% |
| 2021 | $1.5B | +21.6% |
| 2020 | $1.2B | −1.1% |
| 2019 | $1.2B | +14.1% |
| 2018 | $1.1B | +9.9% |
| 2017 | $991M | +9.5% |
| 2016 | $905M | +6.3% |
| 2015 | $851M | −0.9% |
| 2014 | $858M | +17.0% |
| 2013 | $733M | +5.2% |
| 2012 | $697M | +8.6% |
| 2011 | $642M | +16.8% |
| 2010 | $550M | +8.1% |
| 2009 | $509M | +5.9% |
| 2008 | $481M | — |